Information and interesting ideas

Topics posted here will be in the realm of bioanalysis and biomarkers as part of new therapeutic development, with the occasional post of scientific topics that I find interesting.

Thursday, May 25, 2023

Draft ICH E6(R3) Good Clinical Practice released for Consultation

The draft E6(R3), that is revision 3, of the Good Clinical Practice guideline was released as draft for Consultation on 19 May by the ICH Assembly after completion by the Expert Working Group.  Expect countries globally to release it for comment also - but that will take time. Those involved in any aspect of clinical trials should assess the revision to the GCPs to assess what has changed, but not act yet to change their practices as the final guidance will surely contain some differences. The volume of comments will be high given the topic and content; which runs to 73 pages with Appendices.

No comments:

Post a Comment

FDA and CMS issue statement on LDTs: Americans Deserve Accurate and Reliable Diagnostic Tests, Wherever They Are Made

This joint statement notes the evolution of Laboratory Developed Tests (LDTs) from the initial rule and approach the FDA had for oversite, a...